Trends in Inflammatory Bowel Disease Therapy 1999 :
نام عام مواد
[Book]
ساير اطلاعات عنواني
the proceedings of a symposium organized by AXCAN PHARMA, held in Vancouver, BC, August 27-29, 1999
نام نخستين پديدآور
edited by C.N. Williams, R.F. Bursey, D.G. Gall, F. Martin, R.S. McLeod, L.R. Sutherland, J.L. Wallace.
وضعیت نشر و پخش و غیره
محل نشرو پخش و غیره
Dordrecht
نام ناشر، پخش کننده و غيره
Springer Netherlands
تاریخ نشرو بخش و غیره
2000
مشخصات ظاهری
نام خاص و کميت اثر
(xvi, 262 pages)
یادداشتهای مربوط به مندرجات
متن يادداشت
Section I: Genetics --;1 Genetics of Inflammatory bowel disease: where are we? --;2 Genetics of inflammatory bowel disease: why is it important? --;3 Genetics of IBD: impact on immune function --;Section II: Pathogenesis --;4 Bacterial factors in inflammatory bowel disease pathogenesis --;5 Inflammatory bowel disease: autoimmunity or chronic inflammation? --;6 Neutrophil --;epithelial interactions, and efforts to down-regulate them, in inflammatory bowel disease --;7 Understanding inflammatory bowel disease at the millennium: tentative answers and future questions --;Section III: Clinical Challenges in Inflammatory Bowel Disease --;8 Diagnosis of inflammatory bowel disease: an update --;9 Recent developments in the diagnosis and management of paediatric inflammatory bowel disease --;10 Inflammatory bowel disease in the elderly --;Section IV: Current Therapy in Inflammatory Bowel Disease --;11 Induction of remission in ulcerative colitis --;12 Remission maintenance in ulcerative colitis --;13 Induction therapy for Crohn's disease --;14 Maintenance of remission in Crohn's disease --;Section V: Bone Disease in Inflammatory Bowel Disease --;15 Risk factors and prevalence of bone disease in inflammatory bowel disease --;16 Management of low bone mass in patients with inflammatory bowel disease --;17 Steroid-induced osteonecrosis in inflammatory bowel disease: Canadian legal status --;Section VI: Alternative Therapy --;18 Psychotherapy for inflammatory bowel disease: new prospects --;19 The use of complementary and alternative medicine by patients with inflammatory bowel disease --;20 Gut inflammation: is there a role for herbal medicines? --;21 The role of nutrition in the treatment of inflammatory bowel disease --;Section VII: New Therapeutic Approaches --;22 Antibodies to proinflammatory cytokines --;23 Immunomodulation of Crohn's disease --;24 Application of recombinant DNA technology to the identification of novel therapeutic targets in inflammatory bowel disease --;25 The use of probiotics in inflammatory bowel disease.
یادداشتهای مربوط به خلاصه یا چکیده
متن يادداشت
This Trends in Inflammatory Bowel Disease Therapy Symposium was held in Vancouver, British Columbia, Canada, 27~29 August 1999. This is the seventh international symposium, sponsored by Axcan Pharma Canada Inc., since the first symposium in 1986.
موضوع (اسم عام یاعبارت اسمی عام)
موضوع مستند نشده
Gastroenterology.
موضوع مستند نشده
Medicine.
رده بندی کنگره
شماره رده
RC862
.
I53
نشانه اثر
E358
2000
نام شخص به منزله سر شناسه - (مسئولیت معنوی درجه اول )
مستند نام اشخاص تاييد نشده
edited by C.N. Williams, R.F. Bursey, D.G. Gall, F. Martin, R.S. McLeod, L.R. Sutherland, J.L. Wallace.